Conditions: Schizophrenia
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 88
Healthy volunteers: no

Brief summary:
To obtain information on the safety, tolerability and effectiveness of aripiprazole once-monthly in a manner consistent with its intended use in everyday clinical practice in patients with schizophrenia who completed Study 14724A / NCT01795547.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Aripiprazole once-monthly
Intervention descriptions: intervention 1: 400 or 300 mg/month; 6 intramuscular (IM) injections starting at baseline

Protocol document: